0       0

Webinars


WEB190204 - Practical Experiences with Lipid Injectable Emulsions


Feb 4, 2019 2:00pm ‐ Feb 4, 2019 3:30pm


Credits: None available.

Standard: $39.00
Members: $19.00

Description

As an integral component of parenteral nutrition (PN), lipid injectable emulsions (ILEs) are not only a dense source of calories but are also a source of essential fatty acids (EFAs), important for cell membrane development and precursors to key modulators involved in cellular pathways of the immune response. As new products are developed and approved for use, it is imperative for clinicians to understand the indications for each type of ILE and potential outcomes in a variety of patient populations. Join ASPEN for this one of a kind webinar that will begin with a focus on the importance of ILEs in health and disease and the Food and Drug Administration (FDA) indications for all currently available formulations. After you have built your foundation of knowledge on ILEs, you will have the opportunity to hear from your colleagues who will discuss their experiences using ILEs in a variety of patient populations. You will not want to miss the opportunity to enhance your knowledge on ILEs to better care for your patients.

Learning Objectives:

  • List the injectable lipid emulsion products available in the United States and the US Food and Drug Administration (FDA) approved indications for use
  • Identify patients who may potentially benefit from PN with an ILE formulation that contains fish oil (ω-3)
  • Describe the potential impact that conversion to 4-oil lipid emulsion can have on long term HPN patients who are exhibiting early signs of parenteral nutrition-associated liver disease (PNALD).
  • Evaluate changes observed in home PN population of patients transitioned to SMOFlipids over a twelve-month period
  • Review safety and efficacy of four-oil ILE over various treatment durations and examine adverse events and their likelihood of correlation to four-oil ILE
  • Describe how transitioning from SO ILE to Smoflipid ILE can impact bilirubin levels and EFA profile in pediatric intestinal failure patients

Moderator(s):

  • Diego Arenas Moya, MD, Chief of Clinical Nutrition and Functional Medicine, SANVITE, Zapopan, Jalisco, Mexico

Speaker(s):

  • Todd Mattox, PharmD, BCNSP, Medical and Surgical Clinical Pharmacist, Moffitt Cancer Center, Tampa, FL
  • Lisa Mostafavifar, PharmD, BCPS, BCNSP, Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH
  • Casey Cooper, PharmD, CNSC, Pharmacy, Amerita, Inc, Amarillo, TX
  • Hannah Heredia, MS, RD, CNSC, Nutrition Support Dietitian, Parenteral Nutrition, BriovaRx Infusion, Chandler, AZ
  • Mary Beth Harris, RD, MPH, Mott Children's Hospital, University of Michigan
  • Joseph E. Cruz, PharmD, BCPS, Pharmacy, Overlook Medical Center, Summit, NJ
Tags: webinar

Credits Available


You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content